Confirmatory trials are running far behind; how a new Alzheimer's therapy could reach patients

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by   STAT+: Many trials to confirm benefits of drugs granted accelerated approvals are running late By Ed Silverman Adobe Delays can result in drugs staying on the market for years without the predicted clinical benefit being verified, the report concluded. Read More Opinion: How can the latest Alzheimer's therapy reach patients? Follow this trustworthy process By Jason Karlawish Adobe Top-line results for treating Alzheimer's with lecanemab look promising, but there are lessons to be learned from the failure of Aduhelm. Read More Get a Ph.D. in health policy — from a single Powerpoint slide By Bob Herman Spencer Platt/Getty Images Looking for a concise explanation of a half-century's worth of research and arguments about health care spending in the U.S.? You're in luck. Read More Sponsor content by Janssen Immunology A 3-step approach to equitable care in immunology Over the past two decades, scientific innovation has translated into real progress for people living with immune-mediated diseases. Yet disparities in care may prevent people of color from benefitting from the full potential of that innovation. In the journey to shaping an equitable future in immunology, three steps are key. Learn more about the steps the healthcare industry can take to drive health equity in immunology. Nobel Prize in medicine awarded for research into the evolutionary history of humankind By Megan Molteni Christian Charisius/dpa via AP Svante Pääbo accomplished something widely believed to be impossible: recovering and reading DNA from 40,000-year-old bones. Read More Monday, October 3, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser